- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/16 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
Patent holdings for IPC class C07D 295/16
Total number of patents in this class: 116
10-year publication summary
|
24
|
10
|
9
|
5
|
2
|
5
|
2
|
9
|
7
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 3899 |
7 |
| Bristol-myers Squibb Company | 4863 |
5 |
| Araxes Pharma LLC | 89 |
4 |
| EA Pharma Co., Ltd. | 84 |
4 |
| Nippon Soda Co., Ltd. | 883 |
4 |
| Taisho Pharmaceutical Co., Ltd. | 862 |
4 |
| Toyama Chemical Co., Ltd. | 108 |
4 |
| Mitsui Chemicals, Inc. | 3187 |
3 |
| Nanjing Immunophage BioTech Co., Ltd. | 22 |
3 |
| Bayer Schering Pharma AG | 429 |
2 |
| Sumitomo Chemical Company, Limited | 8988 |
2 |
| The Johns Hopkins University | 5533 |
2 |
| Ajinomoto Co., Inc. | 2319 |
2 |
| The Board of Trustees of the University of Illinois | 2666 |
2 |
| Astellas Pharma Inc. | 1125 |
2 |
| Council of Scientific & Industrial Research | 1409 |
2 |
| Hawaii Biotech, Inc. | 26 |
2 |
| Icahn School of Medicine at Mount Sinai | 905 |
2 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 188 |
2 |
| Mitsubishi Tanabe Pharma Corporation | 576 |
2 |
| Other owners | 56 |